• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010-2020) in Oman.阿曼2010年至2020年期间耐碳青霉烯类肠杆菌科细菌的人口统计学、临床和结局特征
IJID Reg. 2022 Aug 4;4:165-170. doi: 10.1016/j.ijregi.2022.08.001. eCollection 2022 Sep.
2
Carbapenem-resistant bloodstream infections: A case-control study from a pediatric referral hospital in Argentina.耐碳青霉烯血流感染:来自阿根廷一家儿科转诊医院的病例对照研究。
Front Public Health. 2022 Aug 25;10:983174. doi: 10.3389/fpubh.2022.983174. eCollection 2022.
3
Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant Bloodstream Infection.耐碳青霉烯类血流感染患者的临床特征及死亡相关因素
Microorganisms. 2023 Apr 25;11(5):1121. doi: 10.3390/microorganisms11051121.
4
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.比较产碳青霉烯酶与不产碳青霉烯酶的耐碳青霉烯类肠杆菌科细菌血症患者的结局
Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9.
5
Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.定植于碳青霉烯类耐药肠杆菌科(CRE)的细菌特性及其与后续感染的相关性。
BMC Infect Dis. 2021 Jul 2;21(1):638. doi: 10.1186/s12879-021-06315-0.
6
Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.美国碳青霉烯类耐药肠杆菌科细菌(CRE)感染中心地区耐碳青霉烯类肠杆菌科细菌(CRE)所致菌血症的多中心临床与分子流行病学分析
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02349-16. Print 2017 Apr.
7
Prevalence and Risk Factors of Carbapenem-resistant Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study.韩国一家三级医院急诊重症监护病房耐碳青霉烯类获得性的流行状况和危险因素:一项病例对照研究。
J Korean Med Sci. 2019 May 13;34(18):e140. doi: 10.3346/jkms.2019.34.e140.
8
Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.碳青霉烯类耐药肠杆菌科菌血症患者死亡的临床和微生物危险因素分析。
Int J Antimicrob Agents. 2020 Oct;56(4):106126. doi: 10.1016/j.ijantimicag.2020.106126. Epub 2020 Aug 2.
9
Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.华北地区一家三甲医院碳青霉烯类耐药肺炎克雷伯菌血流感染的流行率和感染及死亡危险因素的 5 年变化。
Antimicrob Resist Infect Control. 2020 Jun 1;9(1):79. doi: 10.1186/s13756-020-00728-3.
10
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.产非碳青霉烯酶碳青霉烯类耐药肺炎克雷伯菌血症的治疗转归:碳青霉烯类联合治疗的作用。
Clin Ther. 2020 Mar;42(3):e33-e44. doi: 10.1016/j.clinthera.2020.01.004. Epub 2020 Feb 12.

引用本文的文献

1
Carbapenem-resistant Enterobacterales among patients with bloodstream infections in South Africa: Consolidated surveillance data, 2015-2021.南非血流感染患者中耐碳青霉烯类肠杆菌科细菌:2015 - 2021年综合监测数据
PLoS One. 2025 Jul 2;20(7):e0324262. doi: 10.1371/journal.pone.0324262. eCollection 2025.
2
Bacteremia in the Gulf Cooperation Council Region: A Review of the Literature 2013-2023.海湾合作委员会地区的菌血症:2013 - 2023年文献综述
Infect Drug Resist. 2025 May 7;18:2329-2355. doi: 10.2147/IDR.S497241. eCollection 2025.
3
Prevalence of rectal carbapenem resistant Enterobacterales carriage among patients attending healthcare facilities in Ibadan, Nigeria: a descriptive study.在尼日利亚伊巴丹的医疗机构就诊的患者中,直肠携带碳青霉烯类耐药肠杆菌科的流行情况:一项描述性研究。
BMC Infect Dis. 2024 Jul 24;24(1):726. doi: 10.1186/s12879-024-09627-z.
4
Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study.重症监护病房中终末期肾病患者碳青霉烯类耐药革兰阴性菌血流感染的临床结局:一项多中心回顾性观察研究
Infection. 2025 Feb;53(1):197-207. doi: 10.1007/s15010-024-02343-5. Epub 2024 Jul 12.

本文引用的文献

1
Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia.耐碳青霉烯类革兰阴性杆菌或耐万古霉素肠球菌菌血症患者的死亡率预测因素
Infect Drug Resist. 2020 Oct 9;13:3535-3542. doi: 10.2147/IDR.S269087. eCollection 2020.
2
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.在急诊住院后,重症监护病房中耐碳青霉烯类肠杆菌科定植的风险增加。
Emerg Infect Dis. 2020 Jun;26(6):1156-1163. doi: 10.3201/eid2606.190965. Epub 2020 Jun 17.
3
Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy.肠杆菌科细菌中的碳青霉烯酶:检测与抗菌治疗
Front Microbiol. 2019 Aug 20;10:1823. doi: 10.3389/fmicb.2019.01823. eCollection 2019.
4
High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease.高流行率的定植与碳青霉烯类耐药肠杆菌科患者入院越南医院:危险因素和疾病负担。
J Infect. 2019 Aug;79(2):115-122. doi: 10.1016/j.jinf.2019.05.013. Epub 2019 May 21.
5
Infections Caused by Carbapenem-Resistant : An Update on Therapeutic Options.耐碳青霉烯类药物引起的感染:治疗选择的最新进展
Front Microbiol. 2019 Jan 30;10:80. doi: 10.3389/fmicb.2019.00080. eCollection 2019.
6
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.哌拉西林-他唑巴坦与美罗培南对产 ESBLs 的大肠埃希菌或肺炎克雷伯菌血流感染且对头孢曲松耐药患者 30 天死亡率的影响:一项随机临床试验。
JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163.
7
Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.中国某大学医院碳青霉烯类耐药肠杆菌科血流感染的治疗选择和临床结局。
J Infect Public Health. 2019 Jan-Feb;12(1):26-31. doi: 10.1016/j.jiph.2018.08.002. Epub 2018 Aug 23.
8
Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to : Results of a Systematic Literature Review and Meta-analysis.碳青霉烯类耐药与成年住院重症感染患者死亡率之间的关联:一项系统文献综述和荟萃分析的结果
Open Forum Infect Dis. 2018 Jun 28;5(7):ofy150. doi: 10.1093/ofid/ofy150. eCollection 2018 Jul.
9
Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?住院患者耐碳青霉烯类革兰氏阴性菌败血症的临床流行病学:疾病负担转移?
Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26.
10
Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae.耐碳青霉烯类肠杆菌科细菌血流感染的临床及死亡风险因素
Can J Infect Dis Med Microbiol. 2017;2017:6212910. doi: 10.1155/2017/6212910. Epub 2017 Dec 12.

阿曼2010年至2020年期间耐碳青霉烯类肠杆菌科细菌的人口统计学、临床和结局特征

Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010-2020) in Oman.

作者信息

Khamis Faryal, Al-Zakwani Ibrahim, Molai Mariya, Mohsin Jalila, Al Dowaiki Samta, Al Bahrani Maher, Petersen Eskild

机构信息

Infectious Diseases Unit, Department of Internal Medicine, Royal Hospital, Muscat, Oman.

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.

出版信息

IJID Reg. 2022 Aug 4;4:165-170. doi: 10.1016/j.ijregi.2022.08.001. eCollection 2022 Sep.

DOI:10.1016/j.ijregi.2022.08.001
PMID:36059919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9428798/
Abstract

PURPOSE

The incidence of carbapenem-resistant Enterobacteriaceae (CRE) has increased in the last two decades, causing significant morbidity and mortality. Our study investigated the factors associated with mortality from CRE bloodstream infection in a single center in Oman.

METHODS

Data from adult patients with CRE bacteremia, over a 10-year period, were retrospectively collected. Demographic and clinical characteristics were compared according to intensive care unit (ICU) admission status and mortality. A logistic regression model was used to evaluate factors associated with mortality.

RESULTS

169 cases of CRE bacteremia were identified, of whom 93 (55%) required ICU admission and 96 (56.8%) died. Patients who required ICU care were more likely to require organ transplant (15% vs 4.0%;  = 0.02), be on immunosuppressants (31% vs 17%;  = 0.035), be transferred from other hospitals (40% vs 14%; < 0.001), be colonized with CRE (73% vs 43%; < 0.001), have vascular lines (85% vs 42%; < 0.001), be on mechanical ventilation (91% vs 9.2%; < 0.001), require a longer stay (37 vs 17 days; < 0.001), and have increased mortality (80% vs 29%; < 0.001). In the multivariate analysis, mechanical ventilation (adjusted odds ratio (aOR) 15.3; 95% confidence interval 5.39-43.2; < 0.001) and prior use of the broad-spectrum antibiotics meropenem ( = 0.01) and piperacillin/tazobactam ( = 0.026) were associated with CRE mortality.

CONCLUSION

CRE bacteremia carries a high mortality rate in patients requiring ICU care. Implementation of infection control measures and antimicrobial stewardship programs are essential in reducing the rates of CRE BSI.

摘要

目的

耐碳青霉烯类肠杆菌科细菌(CRE)的发病率在过去二十年中有所上升,导致了显著的发病率和死亡率。我们的研究调查了阿曼一个单一中心中与CRE血流感染死亡率相关的因素。

方法

回顾性收集了10年间成年CRE菌血症患者的数据。根据重症监护病房(ICU)入住情况和死亡率比较人口统计学和临床特征。使用逻辑回归模型评估与死亡率相关的因素。

结果

共确定了169例CRE菌血症病例,其中93例(55%)需要入住ICU,96例(56.8%)死亡。需要ICU护理的患者更有可能需要器官移植(15%对4.0%;P = 0.02)、使用免疫抑制剂(31%对17%;P = 0.035)、从其他医院转入(40%对14%;P < 0.001)、被CRE定植(73%对43%;P < 0.001)、有血管通路(85%对42%;P < 0.001)、接受机械通气(91%对9.2%;P < 0.001)、住院时间更长(37天对17天;P < 0.001)以及死亡率更高(80%对29%;P < 0.001)。在多变量分析中,机械通气(调整后的优势比(aOR)为15.3;95%置信区间为5.39 - 43.2;P < 0.001)以及先前使用广谱抗生素美罗培南(P = 0.01)和哌拉西林/他唑巴坦(P = 0.026)与CRE死亡率相关。

结论

在需要ICU护理的患者中,CRE菌血症的死亡率很高。实施感染控制措施和抗菌药物管理计划对于降低CRE血流感染率至关重要。